Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 UBC Acquires Examoto | Contract Pharma

What are you searching for?

Sign in
Breaking News

UBC Acquires Examoto

Bolsters REMS services and innovative risk mitigation solutions for the biopharmaceutical industry.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

UBC, a biopharmaceutical company providing integrated clinical, safety and commercialization services, has acquired Examoto, LLC, a risk evaluation and mitigation strategy (REMS) company. Examoto is dedicated to the design, development, deployment and streamlined operation of technologically driven REMS services in the pharmaceutical market. Transaction terms were not disclosed.

“We are excited by the compelling opportunities this acquisition presents to expand the industry’s leading one-stop-shop for full-service REMS programs,” said Patrick Lindsay, president and CEO, UBC. “The combination of Examoto’s technology-driven approach with UBC’s scientific, technological and operational expertise will ensure the most efficient delivery of successful REMS programs to patients and clients.”

Jason Leedy, Examoto’s founder, said, “Examoto’s technology and design innovations, in concert with UBC’s project management office and related REMS services, creates a REMS powerhouse. We will collectively have the most comprehensive, proven capabilities for risk mitigation solutions for the pharma industry. This strategic combination will encourage efficiency, quality, creativity, and synergy across the various REMS workflows and will provide sponsors with a single point of responsibility for their clinical programs.”

Natalie O’Donnell, corporate vice president, UBC safety and risk management, said, “Today’s healthcare market increasingly demands evidence of drug safety and effectiveness to ensure sufficient validation. Our acquisition of Examoto helps cement UBC’s status as a preeminent leader in this category with a full-service REMS solution that leverages enhanced technologies and product innovations to help mitigate safety risk while optimizing the commercialization and delivery of products to market.”

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics